[go: up one dir, main page]

DE60222238D1 - Zusammensetzung und verfahren zur perkutanen superoxygenierung - Google Patents

Zusammensetzung und verfahren zur perkutanen superoxygenierung

Info

Publication number
DE60222238D1
DE60222238D1 DE60222238T DE60222238T DE60222238D1 DE 60222238 D1 DE60222238 D1 DE 60222238D1 DE 60222238 T DE60222238 T DE 60222238T DE 60222238 T DE60222238 T DE 60222238T DE 60222238 D1 DE60222238 D1 DE 60222238D1
Authority
DE
Germany
Prior art keywords
percutant
superoxygenation
composition
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60222238T
Other languages
English (en)
Inventor
Terrence S Mcgrath
Charles Fox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hydron Technologies Inc
Original Assignee
Hydron Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hydron Technologies Inc filed Critical Hydron Technologies Inc
Application granted granted Critical
Publication of DE60222238D1 publication Critical patent/DE60222238D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Materials For Medical Uses (AREA)
DE60222238T 2001-02-01 2002-01-18 Zusammensetzung und verfahren zur perkutanen superoxygenierung Expired - Lifetime DE60222238D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26581901P 2001-02-01 2001-02-01
PCT/US2002/001521 WO2002060458A2 (en) 2001-02-01 2002-01-18 Compositions and method of tissue superoxygenation

Publications (1)

Publication Number Publication Date
DE60222238D1 true DE60222238D1 (de) 2007-10-18

Family

ID=23011998

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60222238T Expired - Lifetime DE60222238D1 (de) 2001-02-01 2002-01-18 Zusammensetzung und verfahren zur perkutanen superoxygenierung

Country Status (9)

Country Link
US (3) US6649145B2 (de)
EP (1) EP1357920B1 (de)
JP (1) JP2004529090A (de)
CN (1) CN1275601C (de)
AT (1) ATE372124T1 (de)
AU (1) AU2002236795A1 (de)
CA (1) CA2436427A1 (de)
DE (1) DE60222238D1 (de)
WO (1) WO2002060458A2 (de)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110075507A1 (en) * 1997-10-24 2011-03-31 Revalesio Corporation Diffuser/emulsifier
US7654728B2 (en) * 1997-10-24 2010-02-02 Revalesio Corporation System and method for therapeutic application of dissolved oxygen
US6702949B2 (en) 1997-10-24 2004-03-09 Microdiffusion, Inc. Diffuser/emulsifier for aquaculture applications
US6386751B1 (en) 1997-10-24 2002-05-14 Diffusion Dynamics, Inc. Diffuser/emulsifier
US7128278B2 (en) 1997-10-24 2006-10-31 Microdiffusion, Inc. System and method for irritating with aerated water
US6605751B1 (en) * 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
US9119705B2 (en) 1998-06-08 2015-09-01 Thermotek, Inc. Method and system for thermal and compression therapy relative to the prevention of deep vein thrombosis
EP1244476B1 (de) * 1999-12-30 2006-05-31 Acrymed Methode und zusammensetzungen für verbesserte abgabevorrichtungen
US6649145B2 (en) * 2001-02-01 2003-11-18 Hydron Technologies, Inc. Compositions and method of tissue superoxygenation
US20100151041A1 (en) * 2001-07-18 2010-06-17 Eckert C Edward Hypersaturated gas in liquid
US20060030900A1 (en) * 2001-07-18 2006-02-09 Eckert C E Two-phase oxygenated solution and method of use
US7288574B2 (en) * 2001-07-18 2007-10-30 Eckert C Edward Two-phase oxygenated solution and method of use
US20120156309A1 (en) * 2007-09-19 2012-06-21 Eckert C Edward Using Aqueous Oxygenation to Improve Animal Health & Wellness
US20130041312A1 (en) * 2007-09-19 2013-02-14 C. Edward Eckert Using Aqueous Oxygenation to Improve Human Wellness
US8486426B2 (en) 2002-07-29 2013-07-16 Kimberly-Clark Worldwide, Inc. Methods and compositions for treatment of dermal conditions
US8574278B2 (en) 2006-05-09 2013-11-05 Thermotek, Inc. Wound care method and system with one or both of vacuum-light therapy and thermally augmented oxygenation
US8778005B2 (en) 2003-07-18 2014-07-15 Thermotek, Inc. Method and system for thermal and compression therapy relative to the prevention of deep vein thrombosis
WO2005007060A2 (en) 2003-07-18 2005-01-27 Thermotek, Inc. Compression sequenced thermal therapy system
US8100956B2 (en) * 2006-05-09 2012-01-24 Thermotek, Inc. Method of and system for thermally augmented wound care oxygenation
US8128672B2 (en) 2006-05-09 2012-03-06 Thermotek, Inc. Wound care method and system with one or both of vacuum-light therapy and thermally augmented oxygenation
JP4144669B2 (ja) * 2004-03-05 2008-09-03 独立行政法人産業技術総合研究所 ナノバブルの製造方法
JP4059506B2 (ja) * 2004-03-05 2008-03-12 独立行政法人産業技術総合研究所 オゾン水およびその製造方法
KR100583430B1 (ko) * 2004-03-08 2006-05-24 양경숙 차륜 가변형 스쿠터
US20050244354A1 (en) * 2004-04-30 2005-11-03 Sam Speron Oxygenated personal care products
USD679023S1 (en) 2004-07-19 2013-03-26 Thermotek, Inc. Foot wrap
US10016583B2 (en) 2013-03-11 2018-07-10 Thermotek, Inc. Wound care and infusion method and system utilizing a thermally-treated therapeutic agent
US10765785B2 (en) 2004-07-19 2020-09-08 Thermotek, Inc. Wound care and infusion method and system utilizing a therapeutic agent
US10251392B2 (en) * 2004-07-30 2019-04-09 Avent, Inc. Antimicrobial devices and compositions
US8361553B2 (en) 2004-07-30 2013-01-29 Kimberly-Clark Worldwide, Inc. Methods and compositions for metal nanoparticle treated surfaces
NZ592438A (en) 2004-07-30 2012-11-30 Kimberly Clark Co Antimicrobial compositions of silver nanoparticles
US20060034053A1 (en) 2004-08-12 2006-02-16 Thermotek, Inc. Thermal control system for rack mounting
EP1809264B1 (de) * 2004-09-20 2016-04-13 Avent, Inc. Antimikrobielle amorphe zusammensetzungen
US20060275420A1 (en) * 2005-06-03 2006-12-07 BAGLEY David Microstructured water having altered vapor pressure
US20060275421A1 (en) * 2005-06-03 2006-12-07 BAGLEY David Microstructured water having altered melting point
US20100210982A1 (en) * 2006-04-11 2010-08-19 Niran Balachandran Method And System For Providing Segmental Gradient Compression
US8293965B2 (en) * 2006-04-28 2012-10-23 Kimberly-Clark Worldwide, Inc. Antimicrobial site dressings
AU2007249200B2 (en) * 2006-05-15 2013-12-19 Virginia Commonwealth University Methods and compositions for controlled and sustained production and delivery of peroxides
EP2035082A4 (de) * 2006-06-07 2012-02-08 Trinity Wound Inst Llc Sauerstofftherapie mit ultraschall
JP5120998B2 (ja) * 2006-09-06 2013-01-16 国立大学法人 東京医科歯科大学 組織、細胞又は臓器の保存液
US8784897B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of therapeutic treatment of eyes
US8784898B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of wound care and treatment
AU2007349224B2 (en) * 2006-10-25 2014-04-03 Revalesio Corporation Methods of wound care and treatment
US8445546B2 (en) 2006-10-25 2013-05-21 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
US8597689B2 (en) 2006-10-25 2013-12-03 Revalesio Corporation Methods of wound care and treatment
US8609148B2 (en) 2006-10-25 2013-12-17 Revalesio Corporation Methods of therapeutic treatment of eyes
EP2086668B1 (de) 2006-10-25 2016-11-16 Revalesio Corporation Mischvorrichtung und verfahren
JPWO2008072371A1 (ja) * 2006-12-12 2010-03-25 国立大学法人 東京医科歯科大学 組織の殺菌又は消毒用製剤
US7801502B2 (en) * 2006-12-18 2010-09-21 Aai Corporation Method for implementing continuous radio frequency (RF) alignment in advanced electronic warfare (EW) signal stimulation systems
US8147876B2 (en) * 2007-02-27 2012-04-03 National University Corporation Tokyo Medical And Dental University Medical agent for preventing or treating diseases resulting from one of inflammation and remodeling, and method for preventing or treating the diseases
USD662214S1 (en) 2007-04-10 2012-06-19 Thermotek, Inc. Circumferential leg wrap
US20080262413A1 (en) * 2007-04-19 2008-10-23 Ladizinsky Daniel A Method For Supplying Oxygenated Water To Promote Internal Healing
AU2014200002B2 (en) * 2007-10-25 2016-05-19 Revalesio Corporation Bacteriostatic or bacteriocidal compositions and methods
US9745567B2 (en) 2008-04-28 2017-08-29 Revalesio Corporation Compositions and methods for treating multiple sclerosis
US10125359B2 (en) 2007-10-25 2018-11-13 Revalesio Corporation Compositions and methods for treating inflammation
US20120114702A1 (en) * 2007-10-25 2012-05-10 Revalesio Corporation Compositions and methods for treating asthma and other lung disorders
US20090227018A1 (en) * 2007-10-25 2009-09-10 Revalesio Corporation Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
US20090263495A1 (en) * 2007-10-25 2009-10-22 Revalesio Corporation Bacteriostatic or bacteriocidal compositions and methods
WO2009055614A1 (en) * 2007-10-25 2009-04-30 Revalesio Corporation Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation
US20100310665A1 (en) * 2007-10-25 2010-12-09 Revalesio Corporation Bacteriostatic or bacteriocidal compositions and methods
EP2207669A4 (de) * 2007-10-25 2011-11-02 Revalesio Corp Bakteriostatische oder bakteriozide zusammensetzungen und verfahren
US10226610B2 (en) 2007-10-26 2019-03-12 Electrochemical Oxygen Concepts, Inc. Apparatus and methods for controlling tissue oxygenation for wound healing and promoting tissue viability
US8287506B2 (en) 2007-10-26 2012-10-16 Electrochemical Oxygen Concepts, Inc. Apparatus and methods for controlling tissue oxygenation for wound healing and promoting tissue viability
US8758419B1 (en) 2008-01-31 2014-06-24 Thermotek, Inc. Contact cooler for skin cooling applications
WO2009102487A2 (en) * 2008-02-13 2009-08-20 Oxygen Biotherapeutics, Inc. Gas based wound and tissue therapeutics
US20100292632A1 (en) * 2008-02-15 2010-11-18 Mulvihill Maureen L Transdermal Micro-Patch
CN102076326B (zh) * 2008-04-28 2015-12-02 利发利希奥公司 治疗多发性硬化的组合物和方法
US8980325B2 (en) 2008-05-01 2015-03-17 Revalesio Corporation Compositions and methods for treating digestive disorders
WO2010033187A1 (en) * 2008-09-19 2010-03-25 Oxygen Biotherapeutics, Inc. Deep immersion flotation therapy for burn victims
AU2015201152B2 (en) * 2008-10-24 2016-11-17 Electrochemical Oxygen Concepts, Inc Apparatus and methods for controlling tissue oxygenation for wound healing and promoting tissue viability
US20100190004A1 (en) * 2008-11-24 2010-07-29 Gibbins Bruce L Antimicrobial laminate constructs
US8343515B2 (en) 2008-11-25 2013-01-01 Oxygen Biotherapeutics, Inc. Perfluorocarbon gel formulations
US20100144597A1 (en) * 2008-12-10 2010-06-10 Ward Kevin R Novel combinatorial approaches to enhancing oxygen transport to tissues
CA2758738A1 (en) * 2009-04-27 2010-11-04 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
US8815292B2 (en) 2009-04-27 2014-08-26 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
EP2470287A4 (de) 2009-08-28 2015-01-21 Univ Columbia Systeme, verfahren und vorrichtungen zur herstellung gasgefüllter mikroblasen
EP2477550A4 (de) 2009-09-15 2013-12-04 Univ Columbia Systeme, verfahren und vorrichtungen für mikrobläschen
US20110172591A1 (en) * 2010-01-13 2011-07-14 Bacoustics Llc Portable topical hyperbaric skin therapy and wound treatment system
US8409628B2 (en) 2010-02-04 2013-04-02 Penguin IP Holdings, Inc. Methods and compositions for oxygenation of skin to treat skin disorders
US8900601B2 (en) 2010-03-31 2014-12-02 Jennifer Bartels Permeable mixtures, methods and compositions for the skin
EP2566460A4 (de) 2010-05-07 2015-12-23 Revalesio Corp Zusammensetzungen und verfahren für verbesserte sportliche leistungen und verkürzte erholungszeiten
BR112013003110A2 (pt) 2010-08-12 2016-06-28 Revalesio Corp composições e métodos para tratamento de taupatia
US8532729B2 (en) 2011-03-31 2013-09-10 Covidien Lp Moldable ear sensor
US8577435B2 (en) 2011-03-31 2013-11-05 Covidien Lp Flexible bandage ear sensor
US8768426B2 (en) 2011-03-31 2014-07-01 Covidien Lp Y-shaped ear sensor with strain relief
SG194536A1 (en) * 2011-04-19 2013-12-30 Invisiderm Llc Method of producing substances with supersaturated gas,transdermal delivery device thereof, and uses thereof
US10512587B2 (en) 2011-07-27 2019-12-24 Thermotek, Inc. Method and apparatus for scalp thermal treatment
US8652531B2 (en) 2011-07-29 2014-02-18 Kimberly-Clark Worldwide, Inc. Indicator for oxygen generation
US9181093B2 (en) 2011-07-29 2015-11-10 Avent, Inc. Two part oxygen generating system
US20130079800A1 (en) * 2011-08-04 2013-03-28 C. Edward Eckert Method for debriding human tissue
EP2744519B1 (de) * 2011-08-16 2018-10-03 Kate Somerville Skincare LLC Hautverjüngungszusammensetzungen
US9561134B2 (en) 2011-09-14 2017-02-07 Matthew T. Scholz Positive pressure medical dressings with valve and kits containing same
EP2614833A1 (de) 2012-01-13 2013-07-17 SastoMed GmbH Narbenbildung verringernde Wundbehandlung
US10130800B2 (en) 2012-01-27 2018-11-20 Invisiderm, Llc Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
US8573198B2 (en) * 2012-03-01 2013-11-05 Outcome Solutions, Llc Devices and methods for aerosol therapy using hyperbaric tonometry
US10149927B2 (en) 2012-04-24 2018-12-11 Thermotek, Inc. Method and system for therapeutic use of ultra-violet light
US10300180B1 (en) 2013-03-11 2019-05-28 Thermotek, Inc. Wound care and infusion method and system utilizing a therapeutic agent
US9132295B2 (en) 2013-08-23 2015-09-15 Indermica, Inc. Composition having stabilized perfluorocarbons
US9669233B2 (en) 2013-11-11 2017-06-06 Thermotek, Inc. Method and system for wound care
US10702686B2 (en) 2017-06-30 2020-07-07 Electrochemical Oxygen Concepts, Inc. Wound oxygen supply system
US20220378710A1 (en) * 2018-04-23 2022-12-01 Truly Oxygen, Inc. Therapeutic Gas Microfoam for Skin Recovery
WO2019209722A1 (en) * 2018-04-23 2019-10-31 Respirogen, Inc. Oxygenated skin lotion
US20190328660A1 (en) * 2018-04-26 2019-10-31 Zvi Yaniv Nanobubbles in an absorbent material
TWI686210B (zh) 2018-06-01 2020-03-01 國立清華大學 用以誘導病變組織血管正常化的套組及其用途
US20230218522A1 (en) * 2020-04-24 2023-07-13 Gis Ventures Inc. Uses of super-oxygenated water and gel

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981000002A1 (en) * 1979-06-25 1981-01-08 Suntech Use of perfluorocarbon as burn treatment
HUT45875A (en) 1987-02-27 1988-09-28 Mester Coop Elelmiszeripari Es Method for producing and novel delivering protective drink saturated by molecular oxygen
US4801291A (en) 1987-11-18 1989-01-31 Loori Phillip E Portable topical hyperbaric apparatus
US5029579A (en) 1989-01-13 1991-07-09 Ballard Medical Products Hyperbaric oxygenation apparatus and methods
US5154697A (en) 1991-04-02 1992-10-13 Topox, Inc. Collapsible topical hyperbaric apparatus
US5409688A (en) 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
US5516517A (en) * 1994-05-02 1996-05-14 Exfoliation Cleansing Hydration Oxygenation Corporation Method for nutritional oxygenation of the skin
US6607698B1 (en) 1997-08-15 2003-08-19 Therox, Inc. Method for generalized extracorporeal support
US5814222A (en) * 1995-03-31 1998-09-29 Life International Products, Inc. Oxygen enriched liquids, method and apparatus for making, and applications thereof
US5578022A (en) * 1995-04-12 1996-11-26 Scherson; Daniel A. Oxygen producing bandage and method
HU213450B (en) * 1995-04-26 1997-06-30 Ladanyi Jozsef Gel contains gelatin and process for producing it
US5792090A (en) 1995-06-15 1998-08-11 Ladin; Daniel Oxygen generating wound dressing
KR100267626B1 (ko) * 1996-01-24 2000-10-16 듀앙 듀참 액체를 산소화시키는 방법과 산소화장치 및 산소화된 액체
US5834519A (en) * 1996-10-11 1998-11-10 Wayne State University Stabilized gas-supersaturated emulsions and suspensions
US5869538A (en) * 1996-11-26 1999-02-09 Research Foundation Of State University Of New York Method for enhancing transport of gases to tissues
US6127428A (en) * 1996-11-26 2000-10-03 The Research Foundation Of State University Of New York Method for enhancing transport of gases to tissues
CA2299205A1 (en) * 1999-03-09 2000-09-09 Oxy L'eau Inc. Super-oxygenated water solutions and methods of use
US6649145B2 (en) * 2001-02-01 2003-11-18 Hydron Technologies, Inc. Compositions and method of tissue superoxygenation
US7288574B2 (en) * 2001-07-18 2007-10-30 Eckert C Edward Two-phase oxygenated solution and method of use

Also Published As

Publication number Publication date
US20040166171A1 (en) 2004-08-26
CA2436427A1 (en) 2002-08-08
AU2002236795A1 (en) 2002-08-12
US6649145B2 (en) 2003-11-18
US20090104237A1 (en) 2009-04-23
CN1499977A (zh) 2004-05-26
US20030083610A1 (en) 2003-05-01
WO2002060458A3 (en) 2003-05-01
WO2002060458A2 (en) 2002-08-08
ATE372124T1 (de) 2007-09-15
CN1275601C (zh) 2006-09-20
EP1357920B1 (de) 2007-09-05
EP1357920A2 (de) 2003-11-05
JP2004529090A (ja) 2004-09-24

Similar Documents

Publication Publication Date Title
ATE372124T1 (de) Zusammensetzung und verfahren zur perkutanen superoxygenierung
DE60219793D1 (de) Methode zur behandlung von zytokinvermittelten erkrankungen
ATE407676T1 (de) Topoisomerasehemmern zur behandlung von chirurgischen verklebungen
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
TR200103493T2 (tr) Metaloproteaz önleyicileri
SE0102315D0 (sv) Compounds
NO20065079L (no) Materialer og metoder for behandling av koaguleringssykdommer
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
WO2002091999A3 (en) Treatment for wounds
DE502004005033D1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
DE602004011394D1 (en) Thiazolderivate
WO2005018535A3 (en) Compositions and methods for treatment of severe acute respiratory syndrome (sars)
AU2003278667A1 (en) Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
IL152450A (en) Compounds and compositions for use in treating tnf-?? mediated conditions
DE50206761D1 (de) Fluorhaltige copolymere, deren herstellung und verwendung
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
ECSP055844A (es) Nuevos compuestos triciclicos
DE602004028574D1 (de) Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie
SE0004101D0 (sv) New use
DE602005016993D1 (de) Benzothiazolium Verbindungen zur Verwendung in Methoden zur Hemmung der NO Produktion und von TNF alpha und zur Behandlung von Coronavirus Infektionen
ATE469646T1 (de) Pyrazolo-heteroaryl-verbindungen zur behandlung tnf-alpha- und il-1-vermittelter krankheiten
DE50114181D1 (de) Verwendung von 1-phenyl-3-dimethylamino-propan-verbindungen zur therapie der harninkontinenz
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
CY1110156T1 (el) Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης

Legal Events

Date Code Title Description
8332 No legal effect for de